The document discusses decisions that ZyrTex needs to focus on and evaluate later regarding the launch of a new product. It identifies three decisions to focus on now: 1) finalizing production of the new product, 2) setting the marketing strategy and go-to-market plan, and 3) defining key performance indicators to measure impact on sales. Two decisions are identified to evaluate later: 1) whether to sell the Delta division upon analyzing performance of the new product launch, and 2) focusing on manufacturing-related issues like the production plant after finalizing the development process. The rationale provided is that the company needs to focus resources on completing development and launch of the new product before evaluating other strategic decisions.